|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/107 | |
| A61K 47/44 | |||
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61K 9/48 | |||
| A61K 47/14 | |||
| A61K 31/58 |
| (11) | Number of the document | 3157508 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15729188.1 |
| Date of filing the European patent application | 2015-06-17 | |
| (97) | Date of publication of the European application | 2017-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/063606 |
| Date | 2015-06-17 |
| (87) | Number | WO 2015/193380 |
| Date | 2015-12-23 |
| (30) | Number | Date | Country code |
| 14173067 | 2014-06-19 | EP |
| (72) |
H JGAARD, Bent, DK
|
| (73) |
Solural Pharma Aps,
Energivej 42, 2750 Ballerup,
DK
|
| (54) | SOLID ORAL DOSAGE FORM OF LIPOPHILIC COMPOUNDS |
| SOLID ORAL DOSAGE FORM OF LIPOPHILIC COMPOUNDS |